APEIROGONE
The computed 12-month bankruptcy probability of APEIROGONE is 0.6% (low). The 2025 annual accounts show equity of €8k and a net result of €-112. Its solvency ranks better than 56% of 4688 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €8k |
| Net result | €-112 |
| Better than sector | 56% |
| Active | 2 yrs |
Mixed profile: strong on solvency, weaker on profitability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 62.9% | 55.2% | |
| Net result | €-112 | €38k | |
| Equity | €8k | €64k | |
| Gross operating margin | €-99 | €61k | |
| Total assets | €12k | €145k |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | - |
| Net profit | €-112 |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €12k |
| Equity | €8k |
| Debt | €5k |
| of which ≤ 1y | €5k |
| of which > 1y | - |
| Working capital | €8k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 2.69 |
| Quick ratio | 2.69 |
| Working capital ratio | 62.9% |
| Solvency | 62.9% |
| Debt / equity | 0.59 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -0.9% |
| ROE | -1.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €12k |
| Current assets | 29/58 | €12k |
| Amounts receivable within one year | 40/41 | €7k |
| Cash & bank | 54/58 | €6k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €12k |
| Equity | 10/15 | €8k |
| Accumulated profits (losses) | 14 | €8k |
| Amounts payable | 17/49 | €5k |
| Amounts payable within one year | 42/48 | €5k |
| Trade debts payable within one year | 44 | €2k |
| Income statement | ||
| Gross operating margin | 9900 | €-99 |
| Operating result | 9901 | €-99 |
| Financial income | 75 | €143 |
| Financial charges | 65 | €155 |
| Result before taxes | 9903 | €-112 |
| Net result for the period | 9904 | €-112 |
| Result to be appropriated | 9905 | €-112 |
| NACE primary | Head offices & management consulting(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 30-01-2024 |
| Status | Active |
| Postal code | 5640 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92087F0033/00G000 | Wallonia | 397 m² | 1 · 200 m² | 14.2 m · 4 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | APEIROGONE |
| Trade nameFR | APEIROGONE |